Exchange Announcement • 29 Sep 2026 16:36
2026 Interim Report
Exchange Announcement • 28 Sep 2026 18:09
Voluntary Announcement - Jaypirca (Pirtobrutinib) Approved In China For A New Indication In Chronic Lymphocytic Leukemia (Cll) /Small Lymphocytic Lymphoma (Sll) Across All Lines Of Therapy
Exchange Announcement • 01 Sep 2026 22:48
Grant Of Share Options And Restricted Shares
Exchange Announcement • 01 Sep 2026 20:16
List Of Directors And Their Role And Function
Exchange Announcement • 27 Aug 2026 22:50
